Halozyme Therapeutics
Enables subcutaneous delivery of partner medicines through ENHANZE technology.
$105.06
After-hours close−0.29 (−0.28%)
At close$105.35(−1.47%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $2.24 | — | — |
| Aug 2026 | $1.79 | $2.28 | +27.4% |
| May 2026 | $1.54 | $1.60 | +3.9% |
| Feb 2026 | $2.15 | −$0.24 | −111.2% |
| Nov 2025 | $1.63 | $1.72 | +5.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | $2.24 | — | — | $482.3M | — | — |
| Aug 6, 2026 | $1.79 | $2.28 | +27.4% | $402.3M | $481.0M | +19.6% |
| May 11, 2026 | $1.54 | $1.60 | +3.9% | $358.6M | $376.7M | +5.0% |
| Feb 17, 2026 | $2.15 | −$0.24 | −111.2% | $435.7M | $451.8M | +3.7% |
| Nov 3, 2025 | $1.63 | $1.72 | +5.5% | $446.5M | $354.3M | −20.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 18, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 20, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Feb 21, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 10, 2022 | ||||||
| Feb 22, 2022 | ||||||
| Nov 2, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 10, 2021 | ||||||
| Feb 23, 2021 | ||||||
| Nov 2, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 11, 2020 | ||||||
| Feb 24, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 21, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 10, 2018 | ||||||
| Feb 20, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 9, 2016 | ||||||
| Feb 29, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 10, 2015 | ||||||